Unknown

Dataset Information

0

Modeling to capture bystander-killing effect by released payload in target positive tumor cells.


ABSTRACT: BACKGROUND:Antibody-drug conjugates (ADCs) are intended to bind to specific positive target antigens and eradicate only tumor cells from an intracellular released payload through the lysosomal protease. Payloads, such as MMAE, have the capacity to kill adjacent antigen-negative (Ag-) tumor cells, which is called the bystander-killing effect, as well as directly kill antigen-positive (Ag+) tumor cells. We propose that a dose-response curve should be independently considered to account for target antigen-positive/negative tumor cells. METHODS:A model was developed to account for the payload in Ag+/Ag- cells and the associated parameters were applied. A tumor growth inhibition (TGI) effect was explored based on an ordinary differential equation (ODE) after substituting the payload concentration in Ag+/Ag- cells into an Emax model, which accounts for the dose-response curve. To observe the bystander-killing effects based on the amount of Ag+/Ag- cells, the Emax model is used independently. TGI models based on ODE are unsuitable for describing the initial delay through a tumor-drug interaction. This was solved using an age-structured model based on the stochastic process. RESULTS:β∈(0,1] is a fraction parameter that determines the proportion of cells that consist of Ag+/Ag- cells. The payload concentration decreases when the ratio of efflux to influx increases. The bystander-killing effect differs with varying amounts of Ag+ cells. The larger β is, the less bystander-killing effect. The decrease of the bystander-killing effect becomes stronger as Ag+ cells become larger than the Ag- cells. Overall, the ratio of efflux to influx, the amount of released payload, and the proportion of Ag+ cells determine the efficacy of the ADC. The tumor inhibition delay through a payload-tumor interaction, which goes through several stages, may be solved using an age-structured model. CONCLUSIONS:The bystander-killing effect, one of the most important topics of ADCs, has been explored in several studies without the use of modeling. We propose that the bystander-killing effect can be captured through a mathematical model when considering the Ag+ and Ag- cells. In addition, the TGI model based on the age-structure can capture the initial delay through a drug interaction as well as the bystander-killing effect.

SUBMITTER: Byun JH 

PROVIDER: S-EPMC6399851 | biostudies-other | 2019 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications

Modeling to capture bystander-killing effect by released payload in target positive tumor cells.

Byun Jong Hyuk JH   Jung Il Hyo IH  

BMC cancer 20190304 1


<h4>Background</h4>Antibody-drug conjugates (ADCs) are intended to bind to specific positive target antigens and eradicate only tumor cells from an intracellular released payload through the lysosomal protease. Payloads, such as MMAE, have the capacity to kill adjacent antigen-negative (Ag-) tumor cells, which is called the bystander-killing effect, as well as directly kill antigen-positive (Ag+) tumor cells. We propose that a dose-response curve should be independently considered to account for  ...[more]

Similar Datasets

| S-EPMC7756782 | biostudies-literature
| S-EPMC5505002 | biostudies-literature
| S-EPMC8237573 | biostudies-literature
| S-EPMC5344502 | biostudies-literature
| S-EPMC4180774 | biostudies-literature
| S-EPMC7779838 | biostudies-literature
| S-EPMC5570333 | biostudies-other
| S-EPMC4292458 | biostudies-other
| S-EPMC129772 | biostudies-literature
| S-EPMC8533914 | biostudies-literature